These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38241700)
41. Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid Leukemia. Liu Y; Li Q; Alikarami F; Barrett DR; Mahdavi L; Li H; Tang S; Khan TA; Michino M; Hill C; Song L; Yang L; Li Y; Pokharel SP; Stamford AW; Liverton N; Renzetti LM; Taylor S; Watt GF; Ladduwahetty T; Kargman S; Meinke PT; Foley MA; Shi J; Li H; Carroll M; Chen CW; Gardini A; Maillard I; Huggins DJ; Bernt KM; Wan L Cancer Discov; 2022 Nov; 12(11):2684-2709. PubMed ID: 36053276 [TBL] [Abstract][Full Text] [Related]
43. Tandemly Integrated HPV16 Can Form a Brd4-Dependent Super-Enhancer-Like Element That Drives Transcription of Viral Oncogenes. Dooley KE; Warburton A; McBride AA mBio; 2016 Sep; 7(5):. PubMed ID: 27624132 [TBL] [Abstract][Full Text] [Related]
44. BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones. Kanno T; Kanno Y; LeRoy G; Campos E; Sun HW; Brooks SR; Vahedi G; Heightman TD; Garcia BA; Reinberg D; Siebenlist U; O'Shea JJ; Ozato K Nat Struct Mol Biol; 2014 Dec; 21(12):1047-57. PubMed ID: 25383670 [TBL] [Abstract][Full Text] [Related]
45. Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets. Qian H; Zhu M; Tan X; Zhang Y; Liu X; Yang L Cell Death Discov; 2023 Dec; 9(1):470. PubMed ID: 38135679 [TBL] [Abstract][Full Text] [Related]
47. Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells. Gonzales-Cope M; Sidoli S; Bhanu NV; Won KJ; Garcia BA BMC Genomics; 2016 Feb; 17():95. PubMed ID: 26847871 [TBL] [Abstract][Full Text] [Related]
48. Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer. Hashimoto M; Masuda T; Nakano Y; Tobo T; Saito H; Koike K; Takahashi J; Abe T; Ando Y; Ozato Y; Hosoda K; Higuchi S; Hisamatsu Y; Toshima T; Yonemura Y; Hata T; Uemura M; Eguchi H; Doki Y; Mori M; Mimori K Cancer Sci; 2024 Jun; 115(6):1866-1880. PubMed ID: 38494600 [TBL] [Abstract][Full Text] [Related]
49. Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins. Lockwood WW; Zejnullahu K; Bradner JE; Varmus H Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19408-13. PubMed ID: 23129625 [TBL] [Abstract][Full Text] [Related]
50. MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinase. Sooraj D; Sun C; Doan A; Garama DJ; Dannappel MV; Zhu D; Chua HK; Mahara S; Wan Hassan WA; Tay YK; Guanizo A; Croagh D; Prodanovic Z; Gough DJ; Wan C; Firestein R Mol Cell; 2022 Jan; 82(1):123-139.e7. PubMed ID: 34910943 [TBL] [Abstract][Full Text] [Related]
51. Aberrant Super-Enhancer Landscape in Human Hepatocellular Carcinoma. Tsang FH; Law CT; Tang TC; Cheng CL; Chin DW; Tam WV; Wei L; Wong CC; Ng IO; Wong CM Hepatology; 2019 Jun; 69(6):2502-2517. PubMed ID: 30723918 [TBL] [Abstract][Full Text] [Related]
52. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Zuber J; Shi J; Wang E; Rappaport AR; Herrmann H; Sison EA; Magoon D; Qi J; Blatt K; Wunderlich M; Taylor MJ; Johns C; Chicas A; Mulloy JC; Kogan SC; Brown P; Valent P; Bradner JE; Lowe SW; Vakoc CR Nature; 2011 Aug; 478(7370):524-8. PubMed ID: 21814200 [TBL] [Abstract][Full Text] [Related]
53. Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression. Fang K; Huang W; Sun YM; Chen TQ; Zeng ZC; Yang QQ; Pan Q; Han C; Sun LY; Luo XQ; Wang WT; Chen YQ Genome Biol; 2020 Nov; 21(1):269. PubMed ID: 33143730 [TBL] [Abstract][Full Text] [Related]
54. Hold the MYCrophone: MYC Invades Enhancers to Control Cancer-Type Gene Programs. MacPherson-Hawthorne K; Sears RC Cancer Res; 2024 Jul; 84(14):2227-2228. PubMed ID: 38695859 [TBL] [Abstract][Full Text] [Related]
55. Super-enhancers and novel therapeutic targets in colorectal cancer. Liu Q; Guo L; Lou Z; Xiang X; Shao J Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481 [TBL] [Abstract][Full Text] [Related]
56. Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer. Ali A; Shafarin J; Unnikannan H; Al-Jabi N; Jabal RA; Bajbouj K; Muhammad JS; Hamad M Int J Biol Sci; 2021; 17(15):4474-4492. PubMed ID: 34803511 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of BET Family Proteins Suppresses African Swine Fever Virus Infection. Zhao Y; Niu Q; Yang S; Yang J; Zhang Z; Geng S; Fan J; Liu Z; Guan G; Liu Z; Zhou J; Hu H; Luo J; Yin H Microbiol Spectr; 2022 Aug; 10(4):e0241921. PubMed ID: 35758684 [TBL] [Abstract][Full Text] [Related]